Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.

Samsung Biologics Co.,Ltd.

207940

Rang in Aktien #496
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Aktienkurs
$1,028.49
Marktkapitalisierung
$47.88B
Veränderung (1 Tag)
-3.67%
Veränderung (1 Jahr)
-18.37%
Land
KR
Handel Samsung Biologics Co.,Ltd. (207940)

Kategorie

Healthcare
EPS für Samsung Biologics Co.,Ltd. (207940)
EPS zum September 2026 TTM: $29.29
Laut den aktuellen Finanzberichten und dem Aktienkurs von Samsung Biologics Co.,Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) $29.29. Am Ende des Jahres 2024 betrug das EPS $15.92 eine Steigerung gegenüber dem EPS von 2023, das $14.31 betrug.
EPS-Verlauf von Samsung Biologics Co.,Ltd. von 2014 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $29.29 9.66%
2025 $26.71 67.81%
2024 $15.92 11.22%
2023 $14.31 2.67%
2022 $13.94 83.14%
2021 $7.61 49.15%
2020 $5.10 26.32%
2019 $4.04 -12.69%
2018 $4.63 -321.12%
2017 $-2.09 -46.75%
2016 $-3.93 -110.46%
2015 $37.57 -1,964.20%
2014 $-2.02 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$17.32 -40.86%
US
$-7.98 -127.25%
US
$-5.29 -118.06%
AU
$13.70 -53.22%
BE
$27.74 -5.29%
NL